Dr Benoit Smeuninx
BSc | MSc | PhD
Benoit is an mid-career researcher who is interested in how we can improve our health-span. As an avid exercise fanatic, Benoit studied Sport and Exercise Sciences at the Catholic University Leuven in Belgium, where he obtained both his BSc and MSc. He then moved to the United Kingdom where he completed an MSc in Exercise Physiology at Loughborough University. It was here that Benoit’s passion for research started.
In 2013, Benoit undertook a PhD at the University of Birmingham under supervision of Prof Leigh Breen investigating the molecular mechanisms underpinning age-related muscle loss. Upon his PhD completion, Benoit completed a 3-year postdoctoral training on a BBSRC funded project at the University of Birmingham investigating the effects of pre-habilitation on bed-rest induced muscle loss in older age.
In 2020, Benoit joined Prof Mark Febbraio’s Cellular and Molecular Metabolism Laboratory where he started investigating metabolic liver disease. In particular, the mechanisms that drive metabolic dysfunction-associated steatohepatitis (MASH) induced liver cancer, also termed hepatocellular carcinoma. Using transgenic mouse models, Benoit is working towards the discovery of novel treatments and biomarkers that will ultimately improve disease outcome.
